Skip to main content
Clinical Trials/ITMCTR2100004565
ITMCTR2100004565
Recruiting
未知

Based on the actual clinical research of real-world traditional Chinese medicine in the treatment of chronic liver failure

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic liver failure
Sponsor
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Inpatients who meet the diagnostic criteria of chronic liver failure in the 2018 Guidelines for the Diagnosis and Treatment of Liver Failure;
  • 2\. Patients with previous liver cirrhosis;
  • 3\. Age between 18 and 65 years old, regardless of gender;
  • 4\. Those who voluntarily participated in this study and signed the informed consent.

Exclusion Criteria

  • 1\. Acute liver failure, subacute liver failure, chronic acute liver failure;
  • 2\. Chronic liver failure caused by other causes (including autoimmune, drug, toxicity and parasitic);
  • 3\. Pregnant or lactating women;
  • 4\. Patients with primary liver cancer;
  • 5\. Patients with other serious systemic diseases and mental illnesses;
  • 6\. Anti\-HIV positive persons;
  • 7\. Those who have participated in other clinical trials within the past 3 months;
  • 8\. Those who are unwilling to cooperate;
  • 9\. At the time of enrollment, he had been combined with cerebral edema, severe infection (including septic shock, deep fungal infection, infection of more than two sites and double infection, etc.), type I hepatorenal syndrome (clinical features are severe, rapid, and progressive renal Failure, oliguria within a few days or 2 weeks, CRE \> 221µmol/L), hepatopulmonary syndrome, hepatic encephalopathy above grade III, and gastrointestinal hemorrhage.

Outcomes

Primary Outcomes

Not specified

Similar Trials